Sequential factor delivery enables efficient workflow for universal gene editing in clinical grade iPS cells
Abstract Human induced pluripotent stem cells (iPSCs) are gaining momentum as a powerful starting material in cell therapy. To fully harness their potential, CRISPR technology permits endogenous gene modifications as well as the introduction of advanced features, to increase the immune compatibility...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Portfolio
2025-09-01
|
| Sarja: | Scientific Reports |
| Linkit: | https://doi.org/10.1038/s41598-025-17876-4 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|